Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
No figures for this period in the company’s filings.
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.50B |
| FY2017, ended Dec 31, 2017 | $6.87B |
| FY2018, ended Dec 31, 2018 | $10.6B |
| FY2019, ended Dec 31, 2019 | $11.1B |
| FY2020, ended Dec 31, 2020 | $10.7B |
| FY2021, ended Dec 31, 2021 | $12.2B |
| FY2022, ended Dec 31, 2022 | $33.8B |
| FY2023, ended Dec 31, 2023 | $41.3B |
| FY2024, ended Dec 31, 2024 | $39.3B |
| FY2025, ended Dec 31, 2025 | $37.3B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $36.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.19B | $1.29B |
| FY2017, ended Dec 31, 2017 | −$337M | $1.49B |
| FY2018, ended Dec 31, 2018 | $594M | $2.43B |
| FY2019, ended Dec 31, 2019 | $2.07B | $3.11B |
| FY2020, ended Dec 31, 2020 | $1.22B | $2.34B |
| FY2021, ended Dec 31, 2021 | $1.01B | $2.42B |
| FY2022, ended Dec 31, 2022 | −$7.37B | $3.32B |
| FY2023, ended Dec 31, 2023 | −$3.13B | $6.16B |
| FY2024, ended Dec 31, 2024 | −$11.3B | $4.43B |
| FY2025, ended Dec 31, 2025 | $727M | $3.09B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | −$3.17B | $2.18B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $300M |
| FY2017, ended Dec 31, 2017 | $7.31B |
| FY2018, ended Dec 31, 2018 | $986M |
| FY2019, ended Dec 31, 2019 | $1.55B |
| FY2020, ended Dec 31, 2020 | $2.09B |
| FY2021, ended Dec 31, 2021 | $3.90B |
| FY2022, ended Dec 31, 2022 | $3.73B |
| FY2023, ended Dec 31, 2023 | $3.78B |
| FY2024, ended Dec 31, 2024 | $5.31B |
| FY2025, ended Dec 31, 2025 | $4.57B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.37B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.97B |
| FY2017, ended Dec 31, 2017 | $14.8B |
| FY2018, ended Dec 31, 2018 | $16.8B |
| FY2019, ended Dec 31, 2019 | $15.4B |
| FY2020, ended Dec 31, 2020 | $15.4B |
| FY2021, ended Dec 31, 2021 | $14.8B |
| FY2022, ended Dec 31, 2022 | $49.0B |
| FY2023, ended Dec 31, 2023 | $43.7B |
| FY2024, ended Dec 31, 2024 | $39.5B |
| FY2025, ended Dec 31, 2025 | $32.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $32.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 274% since FY20.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | 672M |
| FY2021, ended Dec 31, 2021 | 2.43B |
| FY2022, ended Dec 31, 2022 | 2.43B |
| FY2023, ended Dec 31, 2023 | 2.44B |
| FY2024, ended Dec 31, 2024 | 2.45B |
| FY2025, ended Dec 31, 2025 | 2.48B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 2.51B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.37B | $69.0M | — |
| FY2017, ended Dec 31, 2017 | $603M | $39.0M | — |
| FY2018, ended Dec 31, 2018 | $0 | $80.0M | $4.92B |
| FY2019, ended Dec 31, 2019 | — | $142M | — |
| FY2020, ended Dec 31, 2020 | — | $110M | — |
| FY2021, ended Dec 31, 2021 | — | $178M | — |
| FY2022, ended Dec 31, 2022 | — | $412M | — |
| FY2023, ended Dec 31, 2023 | — | $500M | — |
| FY2024, ended Dec 31, 2024 | — | $557M | — |
| FY2025, ended Dec 31, 2025 | — | $769M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | $813M | — |
Valuation
At current price- Market Cap
- $77.7B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.2×
- Price / Book
- 2.4×
- EV / EBITDA
- 28.0×
Growth
Trailing 12 months- Revenue (TTM)
- $36.1B
- Revenue Growth YoY
- −6.1%
- Revenue CAGR 3Y
- 3.3%
- Revenue CAGR 5Y
- 28.4%
- EPS Growth YoY
- −510%
- Net Income Growth YoY
- −512%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- −3.5%
- Net Margin
- −8.8%
- FCF Margin
- 6.0%
- Return on Equity
- −9.2%
Earnings
Trailing 12 months- Net Income
- −$3.17B
- EPS (diluted)
- −$1.27
- EBITDA
- $3.80B
- Operating Income
- −$1.27B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $3.37B
- Total Debt
- $32.0B
- Net Debt
- $28.7B
- Total Assets
- $97.2B
- Total Liabilities
- $63.3B
- Shareholders' Equity
- $32.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.42B
- Capital Expenditure
- $1.24B
- Free Cash Flow
- $2.18B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- —. 5-year monthly returns vs. S&P 500 (SPY)
Every ratio is calculated from the company’s reported figures.